Kodiak Sciences Inc.
Status: Publicly traded
Direct answer
Kodiak Sciences Inc. is publicly traded on NASDAQ under the ticker KOD.
Kodiak Sciences Inc. is a biopharmaceutical firm currently in the clinical development phase, dedicated to discovering, advancing, and bringing to market treatments for various conditions affecting the retina. Their primary drug candidate, KSI-301, is an anti-vascular endothelial growth factor (anti-VEGF) antibody biopolymer. This compound is currently undergoing Phase IIb/III clinical trials, targeting illnesses...
Can you invest in Kodiak Sciences Inc.?
Yes. Kodiak Sciences Inc. is publicly traded on NASDAQ under the ticker KOD.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Kodiak Sciences Inc.
Detailed equity research is provided by MarketSnap.